Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

Quick Read Eli Lilly (LLY) reported Q4 EPS of $7.54 versus $6.67 expected. Eli Lilly projected 2026 revenue of $80-83B. Eli Lilly’s Mounjaro revenue surged 110% to $7.4B in Q4. Zepbound revenue jumped 123% to $4.2B. Eli Lilly achieved operating margins of 45.6% and net margins of 31.7%. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here. Editor's note: A prior version of this article stated Eli Lilly a ...